Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary Hyperlipidemia”

33 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 33 results

Very early researchActive Not RecruitingNCT04862260
What this trial is testing

Cholesterol Disruption in Combination With the Standard of Care in Patients With Advanced Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Ductal AdenocarcinomaPancreatic CancerPancreas Cancer+1 more
CHU de Quebec-Universite Laval 3
Not applicableNot Yet RecruitingNCT07382414
What this trial is testing

Electronic Letters to Improve Patient Activation in IHD: The NUDGE-IHD Trial

Who this might be right for
Coronary Artery DiseaseHypercholesterolemiaLipoprotein(a)+1 more
Tor Biering-Sørensen 100,000
Large-scale testing (Phase 3)Study completedNCT03768427
What this trial is testing

Ezetimibe (EZ)/Atorvastatin (Ator) (MK-0653C) vs. Ator in Chinese Hypercholesterolemic Participants (MK-0653C-439)

Who this might be right for
Hypercholesterolemia
Organon and Co 454
Not applicableStudy completedNCT03110432
What this trial is testing

Prospective German Very High Cardiovascular Risk Patients Dyslipidemia Treatment Indication Registry

Who this might be right for
DyslipoproteinemiasHypercholesterolemia, FamilialFamilial Hypercholesterolemia - Homozygous+1 more
GWT-TUD GmbH 1,695
Post-approval studies (Phase 4)Study completedNCT00891293
What this trial is testing

A Second Open-Label Extension of a Double-Blind, Parallel, Phase IV Study to Assess the Efficacy and Safety of Adjunctive Lovaza® (Formerly Known as Omacor®) Therapy in Hypertriglyceridemic Subjects Treated With Antara™

Who this might be right for
Hypertriglyceridemia
GlaxoSmithKline 93
Post-approval studies (Phase 4)Study completedNCT00833976
What this trial is testing

Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated Hypertriglyceridemia

Who this might be right for
High TriglyceridesHypercholesterolemiaSchizophrenia+2 more
Massachusetts General Hospital 65
Not applicableStudy completedNCT00347217
What this trial is testing

Observational to Investigate the Efficacy of CRESTOR 5mg in Reaching LDL-C Target Goals in Patients Who Are at High Risk for a Cardiovascular Event

Who this might be right for
Hypercholesteremia
AstraZeneca 3,840
Not applicableStudy completedNCT02251834
What this trial is testing

Hispanic Secondary Stroke Prevention Initiative

Who this might be right for
Stroke
University of Miami 200
Not applicableStudy completedNCT00536965
What this trial is testing

Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets

Who this might be right for
HyperlipidemiasAtherosclerosisCoronary Heart Disease+3 more
AstraZeneca 951
Post-approval studies (Phase 4)Active Not RecruitingNCT06249165
What this trial is testing

VictORION-INCLUSION: Evaluating Inclisiran for Cholesterol Managment in Heart Disease

Who this might be right for
Atherosclerotic Cardiovascular Disease
Duke University 130
Testing effectiveness (Phase 2)Ended earlyNCT00004466
What this trial is testing

Pilot Study of Atorvastatin in Children With Chronic Hyperlipidemia Secondary to Nephrotic Syndrome

Who this might be right for
Nephrotic SyndromeHyperlipidemia
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 5
Not applicableStudy completedNCT00723723
What this trial is testing

Compliance With LDL-Lowering Therapy (Study P05467)(COMPLETED)

Who this might be right for
Coronary Heart DiseaseHypercholesterolemiaHyperlipidemia
Organon and Co 555
Not applicableStudy completedNCT04920825
What this trial is testing

Sacha Inchi Oil Supplementation in 3Hs

Who this might be right for
Endocrine and Metabolic Secondary Hypertension
Universiti Sains Malaysia 54
Not applicableStudy completedNCT00236210
What this trial is testing

Controlled Trial of a Novel Community-based Primary and Secondary Cardiovascular Prevention Program

Who this might be right for
Vascular DiseaseDiabetesHypertension+2 more
Group Health Centre 422
Post-approval studies (Phase 4)Study completedNCT00360074
What this trial is testing

Phase 4 Study in Secondary Hypothyroidism: Body Weight Adapted Thyroxin Treatment and Triiodothyronine Supplementation

Who this might be right for
Secondary HypothyroidismHypopituitarismHyperlipidemias
University Hospital Freiburg 25
Large-scale testing (Phase 3)Study completedNCT00221104
What this trial is testing

Japan Statin Treatment Against Recurrent Stroke (J-STARS)

Who this might be right for
Ischemic Stroke
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 1,578
Not applicableStudy completedNCT00536796
What this trial is testing

Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets

Who this might be right for
HyperlipidemiasAtherosclerosisCoronary Heart Disease+3 more
AstraZeneca 1,096
Very early researchLooking for participantsNCT05802121
What this trial is testing

Akkermansia Muciniphilia and Metabolic Side Effects of ADT

Who this might be right for
Prostate CancerMetabolic SyndromeObesity+4 more
Western University 30
Not applicableNot Yet RecruitingNCT07273513
What this trial is testing

"Smart Family Doctor" Assisted Comprehensive Management of Secondary Prevention Among Post Revascularization Patients

Who this might be right for
HypertensionDiabete MellitusHyperlipidemia+2 more
China National Center for Cardiovascular Diseases 951
Post-approval studies (Phase 4)Study completedNCT01409434
What this trial is testing

Long Term Antihypertensive Exposure and Adverse Metabolic Effects: PEAR Follow-Up Study

Who this might be right for
Drug Induced HyperglycemiaSecondary Hyperlipidemia
University of Florida 44
Load More Results